GlassScriptPhysician profile
Jesse Samuel Little
NPI 1174565709
$747.02
in general payments reported to CMS, 2019-2025
16 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.83 · 2020: $174 · 2021: $35.36 · 2022: $91.22 · 2023: $24.07 · 2024: $241 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.14 | 2024-2025 | |
| Axonics, INC. | $127.97 | 2020 | |
| Boston Scientific Corporation | $91.64 | 2024 | Rezum Generator, Spaceoar Vue System - 10ml |
| Blue Earth Diagnostics | $90.00 | 2021-2024 | |
| Astellas Pharma US INC | $66.40 | 2019-2025 | Xtandi |
| Ambu INC. | $38.24 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $27.53 | 2025 | |
| Merck Sharp & Dohme LLC | $24.54 | 2024 | Keytruda |
| Procept Biorobotics Corporation | $23.07 | 2025 | |
| Urogen Pharma, INC. | $19.41 | 2022 | |
| Trevena, INC. | $19.04 | 2021 | |
| Travere Therapeutics, INC. | $18.49 | 2020 | |
| Myovant Sciences INC. | $16.19 | 2022 | |
| Accord Healthcare, INC. | $15.54 | 2024 | |
| Sun Pharmaceutical Industries INC. | $14.92 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.